|
Large-scale observational prospective cohort study of a multi-cancer early detection (MCED) test in symptomatic patients referred for cancer investigation. |
|
|
Research Funding - GRAIL (Inst) |
(OPTIONAL) Uncompensated Relationships - GRAIL |
|
|
No Relationships to Disclose |
|
|
|
|
Stock and Other Ownership Interests - CanSense |
Research Funding - CanSense |
Patents, Royalties, Other Intellectual Property - Holder of published patent and IP related to CanSense Ltd |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Illumina |
|
|
|
Stock and Other Ownership Interests - GRAIL |
Travel, Accommodations, Expenses - GRAIL |
|
|
|
Stock and Other Ownership Interests - GRAIL |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Illumina |
Patents, Royalties, Other Intellectual Property - Patent application by GRAIL for novel work on SYSTEMS AND METHODS FOR AUTOMATED CLASSIFICATION OF A DOCUMENT Patent number: 17/714,826 |
|
|
|
Stock and Other Ownership Interests - Illumina |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Alkermes; Bayer; BiolineRx; Boehringer Ingelheim; Bristol-Myers Squibb; Immunocore |
Research Funding - Amgen (Inst); AstraZeneca (Inst); BiolineRx (Inst); Bristol-Myers Squibb (Inst); GRAIL (Inst); GRAIL (Inst); Immunocore (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Replimune (Inst); Roche (Inst); Salvarx (Inst); Vaccitech (Inst) |
(OPTIONAL) Uncompensated Relationships - GenesisCare |